[Federal Register Volume 86, Number 202 (Friday, October 22, 2021)]
[Notices]
[Page 58692]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-23034]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-912]


Bulk Manufacturer of Controlled Substances Application: Groff NA 
Hemplex LLC

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Groff NA Hemplex LLC has applied to be registered as a bulk 
manufacturer of basic class(es) of controlled substance(s). Refer to 
Supplementary Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before December 21, 
2021. Such persons may also file a written request for a hearing on the 
application on or before December 21, 2021.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on August 16, 2021, Groff NA Hemplex LLC, 100 Redco 
Avenue, Suite A, Red Lion, Pennsylvania 17356-1436, applied to be 
registered as a bulk manufacturer of the following basic class(es) of 
controlled substance(s):

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Marihuana Extract.......................   7350  I
Marihuana...............................   7360  I
Tetrahydrocannabinols...................   7370  I
------------------------------------------------------------------------

    The company is federally authorized to conduct cultivation 
activities in order to bulk manufacture the listed controlled 
substances for internal use and for sale to federally registered 
research investigators. No other activities for these drug codes are 
authorized for this registration.

Brian S. Besser,
Acting Assistant Administrator.
[FR Doc. 2021-23034 Filed 10-21-21; 8:45 am]
BILLING CODE P